{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:43:35Z","timestamp":1787013815571,"version":"build-2736575974"},"reference-count":16,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2022,12,18]],"date-time":"2022-12-18T00:00:00Z","timestamp":1671321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014555","name":"Murdoch Children's Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014555","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1196010"],"award-info":[{"award-number":["1196010"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust NZ J Obst Gynaeco"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:p>Prenatal screening for aneuploidy has undergone immense changes over the past two decades. In 2013 cell\u2010free DNA\u2010based non\u2010invasive prenatal testing (NIPT) became a new self\u2010funded option primarily for Down syndrome screening, but also other aneuploidies and genetic conditions. The numbers of Medicare item claims for prenatal diagnostic procedures have halved since the introduction of NIPT, while billings for serum screening fell by 40% over the same period, on a background of steady births. Australia is now observing historically low rates of prenatal diagnostic testing. These data provide an informative snapshot of historic changes in prenatal screening and diagnosis, as our sector prepares for the impending impacts of other advances in genomics on maternity care. They also highlight the need to address equity and quality issues that arise when consumers must bear the full costs of improved genomic tests in the absence of Medicare funding.<\/jats:p>","DOI":"10.1111\/ajo.13638","type":"journal-article","created":{"date-parts":[[2022,12,18]],"date-time":"2022-12-18T18:35:05Z","timestamp":1671388505000},"page":"264-267","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["A decade of non\u2010invasive prenatal screening in Australia: National impact on prenatal screening and diagnostic testing"],"prefix":"10.1111","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9720-3562","authenticated-orcid":false,"given":"Lisa","family":"Hui","sequence":"first","affiliation":[{"name":"Reproductive Epidemiology Group Murdoch Children's Research Institute  Melbourne Victoria Australia"},{"name":"Department of Obstetrics and Gynaecology University of Melbourne  Melbourne Victoria Australia"},{"name":"Department of Perinatal Medicine Mercy Hospital for Women  Melbourne Victoria Australia"},{"name":"Department of Obstetrics and Gynaecology Northern Health  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Halliday","sequence":"additional","affiliation":[{"name":"Reproductive Epidemiology Group Murdoch Children's Research Institute  Melbourne Victoria Australia"},{"name":"Department of Paediatrics University of Melbourne  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,12,18]]},"reference":[{"key":"e_1_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.13488"},{"key":"e_1_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajo.12117"},{"key":"e_1_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/uog.21899"},{"key":"e_1_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajo.12380"},{"key":"e_1_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2017.55"},{"key":"e_1_2_3_7_1","unstructured":"PynakerC HuiL HallidayJ.Annual report on Prenatal Diagnosis in Victoria 2021 The Victorian Prenatal Diagnosis Database Murdoch Children's Research Institute 2022.https:\/\/doi.org\/10.25374\/MCRI.20479491. Available from URL:https:\/\/www.mcri.edu.au\/images\/research\/projects\/prenatal\u2010screening\/Prenatal_Annual_Report_2021_160822.pdf"},{"key":"e_1_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000275"},{"key":"e_1_2_3_9_1","unstructured":"Australian Government Services Australia. Accessed on 20 March 2022 athttp:\/\/medicarestatistics.humanservices.gov.au\/statistics\/mbs_item.jsp"},{"key":"e_1_2_3_10_1","unstructured":"Australian Bureau of Statistics. Access on 8 July 2022 athttps:\/\/www.abs.gov.au\/statistics\/people\/population\/births\u2010australia\/latest\u2010release"},{"key":"e_1_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/uog.17483"},{"key":"e_1_2_3_12_1","unstructured":"Royal Australian and New Zealand College of Obstetricians and Gynaecologist.Statement C\u2010Obs 59. Prenatal screening and diagnostic testing for fetal chromosomal and genetic conditions. July 2018. [Accessed 22 July 2022.] Available from URL:https:\/\/ranzcog.edu.au\/wp\u2010content\/uploads\/2022\/05\/Prenatal\u2010Screening\u2010and\u2010Diagnostic\u2010Testing\u2010for\u2010Fetal\u2010Chromosomal\u2010and\u2010Genetic\u2010Conditions.pdf"},{"key":"e_1_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajo.12306"},{"key":"e_1_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajo.12778"},{"key":"e_1_2_3_15_1","unstructured":"Australian Government. Medical Services Advisory Committee.Public Summary Document. Application No. 1492 \u2013 Non\u2010invasive prenatal testing (NIPT) for trisomies 21 18 and 13. November 2019. [Accessed 16 Oct 2022.] Available from URL:http:\/\/www.msac.gov.au\/internet\/msac\/publishing.nsf\/Content\/B1BCB2807D09C12DCA258258000F2025\/$File\/1492%20Final%20PSD.pdf"},{"key":"e_1_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-genom-083118-015053"},{"key":"e_1_2_3_17_1","unstructured":"Medicare Services Advisory Committee.Application 1573. Reproductive carrier screening for fragile X syndrome spinal muscular atrophy and cystic fibrosis. [Accessed 19 July 2022.] Available from URL:http:\/\/www.msac.gov.au\/internet\/msac\/publishing.nsf\/Content\/1573\u2010public"}],"container-title":["Australian and New Zealand Journal of Obstetrics and Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajo.13638","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajo.13638","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajo.13638","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T10:33:00Z","timestamp":1692613980000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/ajo.13638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,18]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["10.1111\/ajo.13638"],"URL":"https:\/\/doi.org\/10.1111\/ajo.13638","archive":["Portico"],"relation":{},"ISSN":["0004-8666","1479-828X"],"issn-type":[{"value":"0004-8666","type":"print"},{"value":"1479-828X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,18]]},"assertion":[{"value":"2022-07-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}